Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord

Abstract Background Mesenchymal stromal cells (MSCs) are considered potential candidates that hold great promise in the treatment of immune-related diseases. For therapeutic applications, it is necessary to isolate and expand MSCs with procedures complying with good manufacturing practice (GMP). Rec...

Full description

Bibliographic Details
Main Authors: Sermporn Thaweesapphithak, Chairat Tantrawatpan, Pakpoom Kheolamai, Duangrat Tantikanlayaporn, Sittiruk Roytrakul, Sirikul Manochantr
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-019-1175-3